Compound Profile: HGH Fragment 176-191
HGH Fragment 176-191 is a synthetic peptide comprising the C-terminal amino acid sequence 176-191 of human growth hormone. This 16-amino acid fragment represents the specific region of HGH associated with lipolytic activity in preclinical studies, whilst lacking the growth-promoting effects of full-length growth hormone. The Beligas formulation provides 2mg of research-grade peptide for laboratory investigation. Researchers examining metabolic pathways and fat oxidation mechanisms frequently study this fragment due to its selective action profile. Stroid UK Shop maintains rigorous quality standards for peptide research compounds.
Laboratory Research Applications
Scientific literature demonstrates that HGH Fragment 176-191 exhibits lipolytic properties in adipose tissue models whilst avoiding the anabolic effects associated with intact growth hormone. Cell culture studies indicate this fragment activates adenylyl cyclase pathways leading to increased cyclic adenosine monophosphate (cAMP) levels in fat cells. Animal model research has investigated the fragment’s effects on lipid metabolism, fat oxidation rates, and body composition parameters. Researchers studying obesity mechanisms, metabolic syndrome pathways, and adipocyte biology frequently examine this compound. The fragment’s selectivity for lipolytic rather than growth-promoting pathways makes it valuable for investigating targeted metabolic interventions. Studies exploring peptide fragments demonstrate distinct pharmacological profiles compared to parent hormones. Laboratory investigations encompass molecular signalling pathways, receptor binding kinetics, and downstream metabolic cascades.
Product Specifications
| Parameter | Specification |
|---|---|
| Peptide Sequence | YLRIVQCRSVEGSCGF (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe) |
| Molecular Weight | 1815.1 g/mol |
| CAS Number | Verify with supplier |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilised white powder |
| Storage | -20°C, dry, protected from light |
| Solubility | Water, bacteriostatic water |
| Manufacturer | Beligas Pharmaceuticals |
Researchers conducting SARM studies often examine peptides alongside selective modulators for comparative analysis. The fragment’s stability profile requires appropriate reconstitution protocols and storage conditions for optimal research outcomes. Peptide research compounds demand precise handling procedures to maintain structural integrity and biological activity throughout experimental protocols.
Research Compliance
HGH Fragment 176-191 2mg Beligas is supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must ensure compliance with institutional guidelines and regulatory requirements governing peptide research. Purchase and use must align with laboratory research protocols and scientific study objectives only.
